Mycophenolate mofetil vs methotrexate
Prevention of acute GVHD grade II to IV · people receiving allogeneic hematopoietic stem cell transplantation
It is very uncertain whether mycophenolate mofetil changes prevention of acute GVHD grade II to IV compared with methotrexate (very low certainty).
1 finding from 1 review
- Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic… 2014 · Cochrane Headline outcomes onlyRR 1.25 [0.75, 2.09]3 studies · 174 participantsVery low